comprehensive -WSS

comprehensive

author：entertainment 2025-09-30 12:17:00 - browse：95

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Q&A: Jennifer Adair on making gene therapy available globally

WSS

Why rehabilitation engineers need to center patients in their research

Winning ticket for $1 billion Powerball jackpot sold in California

Driven by the pandemic, applicants flood public health schools

Q&A: Jennifer Adair on making gene therapy available globally

Hospitals struggle to profit from CAR

Bird flu outbreak in cows is latest avian flu curveball

hotspot

comprehensive

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cancer researcher Catriona Jamieson is sending tumors into space

Apple is now the first public company to be valued at $3 trillion

Driven by the pandemic, applicants flood public health schools

Medical leaders decry Supreme Court decision on affirmative action

Stanford president faces new allegations over 1999 paper

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Dogs on Prozac: What pet anti

Peter Hotez and the public health issue of online harassment

Driven by the pandemic, applicants flood public health schools

Wikipedia

Close Medicare's dangerous gaps in addiction treatment coverage

Stanford president faces new allegations over 1999 paper

MultiPlan and major insurers sued for alleged medical price

7 more heat

Health care needs a new profession: neuroimaging counseling

I learned firsthand about improving diversity in clinical trials

leisure time

focus

focus

hotspot